Chirag P. Shah

Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents

Chirag P. Shah, Sunir J. Garg, J.F. Vander et al. · Ophthalmology · 2011 · 228 citations

Ocular Disease, Vitreous Body, Ophthalmology +8

Progression of Geographic Atrophy in Age-related Macular Degeneration

Tiarnán D L Keenan, Elvira Agrón, Amitha Domalpally et al. · Ophthalmology · 2018 · 201 citations

Ocular Disease, Age-related Diseases, Geographic Atrophy +1

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab

Hyung Cho, Chirag P. Shah, Marissa Weber et al. · British Journal of Ophthalmology · 2013 · 161 citations

Treatment of Acute Retinal Necrosis

Michael D. Tibbetts, Chirag P. Shah, Lucy H. Young et al. · Ophthalmology · 2010 · 159 citations

Ocular Disease, Vitreous Body, Ophthalmology +3

Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection

Eugene Milder, J.F. Vander, Chirag P. Shah et al. · Ophthalmology · 2012 · 129 citations

Antimicrobial Susceptibility, Antibiotic Resistance Patterns, Ophthalmology +10